Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Efficacy and Safety of COVID-19 Convalescent Plasma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04397523
Recruitment Status : Completed
First Posted : May 21, 2020
Last Update Posted : May 11, 2021
University Clinic for Infectious Diseases, North Macedonia
Information provided by (Responsible Party):
Institute for Transfusion Medicine of RNM

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 10, 2021
Actual Study Completion Date : May 10, 2021
Huaxia, (2020). 'China puts 245 COVID-19 patients on convalescent plasma therapy',, 2 February. Available at: Accessed on March 30,2020
Guidance on collection, testing, processing, storage, distribution and monitored use. An EU programme of COVID-19 convalescent plasma collection and transfusion. EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY, 08 April, 2020
AABB's CCP Collection Protocol - Donor Eligibility, Processing, Labeling and Distribution, 03 April, 2020